Significant positive associations between PD‐L1+ cells and CD8+ T cells in the TC or infiltration region, evaluated based on the m‐IHC method, and progression‐free survival or response to anti‐PD‐1‐based immunotherapy were demonstrated in metastatic melanoma patients.21 Here, CD8A is linked to metastatic melanoma.